Abstract

Bladder cancer (BC) is a representative of urological cancer with a high recurrence and metastasis potential. Currently, cisplatin-based chemotherapy and immune checkpoint inhibitors are used as standard therapy in patients with advanced/metastatic BC. However, these therapies often show severe adverse events, and prolongation of survival is unsatisfactory. Therefore, a treatment strategy using natural compounds is of great interest. In this review, we focused on the anti-cancer effects of isothiocyanates (ITCs) derived from cruciferous vegetables, which are widely cultivated and consumed in many regions worldwide. Specifically, we discuss the anti-cancer effects of four ITC compounds—allyl isothiocyanate, benzyl isothiocyanate, sulforaphane, and phenethyl isothiocyanate—in BC; the molecular mechanisms underlying their anti-cancer effects; current trends and future direction of ITC-based treatment strategies; and the carcinogenic potential of ITCs. We also discuss the advantages and limitations of each ITC in BC treatment, furthering the consideration of ITCs in treatment strategies and for improving the prognosis of patients with BC.

Highlights

  • Bladder cancer (BC) is recognized as a representative of urological cancer (UC), but it has specific pathological characteristics and treatment strategies

  • The results showed that allyl isothiocyanate (AITC) nanoparticles inhibit cancer cell proliferation and migration; these anti-cancer effects are dependent on AITC concentration; inhibition of cancer cell proliferation and migration is achieved at 70 mg L−1 and 8.75 mg L−1 of AITC nanoparticles, respectively

  • The research suggests that all ITC members can suppress carcinogenesis, tumor development, and progression in vivo and in vitro

Read more

Summary

Introduction

Bladder cancer (BC) is recognized as a representative of urological cancer (UC), but it has specific pathological characteristics and treatment strategies. Yiqi Huayu Jiedu decoction, which comprises various Chinese herbs and natural compounds, was reported to increase the anti-cancer effects of standard chemotherapy in patients with stage III gastric cancer after radical gastrectomy and improve the quality of life of patients [10]. In addition to these reports, several reviews and in vivo and in vitro studies have demonstrated that a variety of natural products possess anti-cancer potential and can avoid the undesirable effects of standard therapies of malignancies [11,12,13,14]. We provide future direction of ITC-based therapy for patients with BC

Isothiocyanates in Cruciferous Vegetables
Allyl Isothiocyanate
In Vitro Studies
N-acetylcysteine Conjugate Allyl Isothiocyanate
In Vivo Studies
Clinical Trials and Future Direction of Allyl Isothiocyanate-Based Therapy
Benzyl Isothiocyanate
Combination Therapy of Benzyl Isothiocyanate and Cisplatin
Sulforaphane
Combination Therapy of Sulforaphane and Other Therapeutic Agents
Phenethyl Isothiocyanate
Combination Therapy of Phenethyl Isothiocyanate and Other Therapeutic Agents
Carcinogenic Potential of Isothiocyanates
Carcinogenic Potential of Benzyl Isothiocyanate
Carcinogenic Potential of Sulforaphane
Carcinogenic Potential of Phenethyl Isothiocyanate
Further Considerations
Findings
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.